Achieving Justice in Genomic Translation
Re-Thinking the Pathway to Benefit
Herausgeber: Burke, Wylie; Goering, Sara; Edwards, Kelly A
Achieving Justice in Genomic Translation
Re-Thinking the Pathway to Benefit
Herausgeber: Burke, Wylie; Goering, Sara; Edwards, Kelly A
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book examines the ethical and social issues that arise in the conduct of genetic research, from the discovery phase, through development and delivery research, to health outcomes.
Andere Kunden interessierten sich auch für
- Post-genomic Approaches in Drug and Vaccine Development129,99 €
- Charlene GalarneauCommunities of Health Care Justice171,99 €
- Sheila ReadingAchieving Competencies for Nursing Practice: A Handbook for Student Nurses43,99 €
- Achieving Steeep Health Care54,99 €
- Norman DanielsJustice and Justification146,99 €
- Robert P RhodesHealth Care Politics, Policy, and Distributive Justice104,99 €
- Steven H. MilesThe Torture Doctors: Human Rights Crimes & the Road to Justice34,99 €
-
-
-
This book examines the ethical and social issues that arise in the conduct of genetic research, from the discovery phase, through development and delivery research, to health outcomes.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Hurst & Co.
- Seitenzahl: 224
- Erscheinungstermin: 15. September 2011
- Englisch
- Abmessung: 236mm x 157mm x 20mm
- Gewicht: 476g
- ISBN-13: 9780195390384
- ISBN-10: 0195390385
- Artikelnr.: 33372834
- Verlag: Hurst & Co.
- Seitenzahl: 224
- Erscheinungstermin: 15. September 2011
- Englisch
- Abmessung: 236mm x 157mm x 20mm
- Gewicht: 476g
- ISBN-13: 9780195390384
- ISBN-10: 0195390385
- Artikelnr.: 33372834
Wylie Burke, MD, PhD, is Professor and Chair of the Department of Bioethics and Humanities at the University of Washington, Seattle, WA. Kelly Edwards, PhD, is an Associate Professor in the Department of Bioethics and Humanities, Core Faculty in the Institute for Public Health Genetics. Sara Goering, PhD, is Assistant Professor of Philosophy and member of the Program on Values in Society and the Program on Disability Studies at the University of Washington, Seattle, WA. Suzanne Holland, PhD, is Professor of Ethics & Religion and Philip M. Phibbs Research Scholar at University of Puget Sound in Tacoma, WA. Susan Trinidad, MA, is a qualitative researcher in the Department of Bioethics and Humanities and a co-investigator with the Center for Genomics and Healthcare Equality.
* 1. Making Good on the Promise of Genetics: Justice in Translational
Science
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 2. The Social, Political, and Economic Underpinnings of Biomedical
Research and Development: A Formidable Status Quo
* Patricia Kuszler
* 3. The Input-Output Problem: Whose DNA Do We Study, and Why Does It
Matter?
* Stephanie Malia Fullerton
* 4. The Autism Genetic Resource Exchange: Changing Pace, Priorities,
and Roles in Discovery Science
* Holly K. Tabor and Martine Lappé
* Commentary on the Discovery Phase of Research
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 5. Early Assessment of Translational Opportunities
* Patricia Deverka and David L. Veenstra
* 6. The power of knowledge: How carrier and prenatal screening altered
the clinical goals of genetic testing
* Commentary on the Development Phase of the Translational Cycle
* 7. Integrating genetic tests into clinical practice: The role of
guidelines
* Anne-Marie Laberge and Wylie Burke
* 8. Genomics and the Health Commons
* Nora Henrikson and Wylie Burke
* Commentary on the Delivery Phase of the Translational Cycle
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 9. The Role of Advocacy in Newborn Screening
* Catharine Riley and Carolyn Watts
* 10. What Outcomes? Whose Benefits?
* Wylie Burke and Nancy Press
* Commentary on the Outcomes Phase of the Translational Cycle
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 11. Bringing the "Best Science" to Bear on Youth Suicide: Why
Community Perspectives Matter
* Rosalina James and Helene Starks
* 12. Conclusion
* Kelly A. Edwards, Sara Goering, Suzanne Holland and Maureen Kelley
Science
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 2. The Social, Political, and Economic Underpinnings of Biomedical
Research and Development: A Formidable Status Quo
* Patricia Kuszler
* 3. The Input-Output Problem: Whose DNA Do We Study, and Why Does It
Matter?
* Stephanie Malia Fullerton
* 4. The Autism Genetic Resource Exchange: Changing Pace, Priorities,
and Roles in Discovery Science
* Holly K. Tabor and Martine Lappé
* Commentary on the Discovery Phase of Research
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 5. Early Assessment of Translational Opportunities
* Patricia Deverka and David L. Veenstra
* 6. The power of knowledge: How carrier and prenatal screening altered
the clinical goals of genetic testing
* Commentary on the Development Phase of the Translational Cycle
* 7. Integrating genetic tests into clinical practice: The role of
guidelines
* Anne-Marie Laberge and Wylie Burke
* 8. Genomics and the Health Commons
* Nora Henrikson and Wylie Burke
* Commentary on the Delivery Phase of the Translational Cycle
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 9. The Role of Advocacy in Newborn Screening
* Catharine Riley and Carolyn Watts
* 10. What Outcomes? Whose Benefits?
* Wylie Burke and Nancy Press
* Commentary on the Outcomes Phase of the Translational Cycle
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 11. Bringing the "Best Science" to Bear on Youth Suicide: Why
Community Perspectives Matter
* Rosalina James and Helene Starks
* 12. Conclusion
* Kelly A. Edwards, Sara Goering, Suzanne Holland and Maureen Kelley
* 1. Making Good on the Promise of Genetics: Justice in Translational
Science
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 2. The Social, Political, and Economic Underpinnings of Biomedical
Research and Development: A Formidable Status Quo
* Patricia Kuszler
* 3. The Input-Output Problem: Whose DNA Do We Study, and Why Does It
Matter?
* Stephanie Malia Fullerton
* 4. The Autism Genetic Resource Exchange: Changing Pace, Priorities,
and Roles in Discovery Science
* Holly K. Tabor and Martine Lappé
* Commentary on the Discovery Phase of Research
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 5. Early Assessment of Translational Opportunities
* Patricia Deverka and David L. Veenstra
* 6. The power of knowledge: How carrier and prenatal screening altered
the clinical goals of genetic testing
* Commentary on the Development Phase of the Translational Cycle
* 7. Integrating genetic tests into clinical practice: The role of
guidelines
* Anne-Marie Laberge and Wylie Burke
* 8. Genomics and the Health Commons
* Nora Henrikson and Wylie Burke
* Commentary on the Delivery Phase of the Translational Cycle
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 9. The Role of Advocacy in Newborn Screening
* Catharine Riley and Carolyn Watts
* 10. What Outcomes? Whose Benefits?
* Wylie Burke and Nancy Press
* Commentary on the Outcomes Phase of the Translational Cycle
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 11. Bringing the "Best Science" to Bear on Youth Suicide: Why
Community Perspectives Matter
* Rosalina James and Helene Starks
* 12. Conclusion
* Kelly A. Edwards, Sara Goering, Suzanne Holland and Maureen Kelley
Science
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 2. The Social, Political, and Economic Underpinnings of Biomedical
Research and Development: A Formidable Status Quo
* Patricia Kuszler
* 3. The Input-Output Problem: Whose DNA Do We Study, and Why Does It
Matter?
* Stephanie Malia Fullerton
* 4. The Autism Genetic Resource Exchange: Changing Pace, Priorities,
and Roles in Discovery Science
* Holly K. Tabor and Martine Lappé
* Commentary on the Discovery Phase of Research
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 5. Early Assessment of Translational Opportunities
* Patricia Deverka and David L. Veenstra
* 6. The power of knowledge: How carrier and prenatal screening altered
the clinical goals of genetic testing
* Commentary on the Development Phase of the Translational Cycle
* 7. Integrating genetic tests into clinical practice: The role of
guidelines
* Anne-Marie Laberge and Wylie Burke
* 8. Genomics and the Health Commons
* Nora Henrikson and Wylie Burke
* Commentary on the Delivery Phase of the Translational Cycle
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 9. The Role of Advocacy in Newborn Screening
* Catharine Riley and Carolyn Watts
* 10. What Outcomes? Whose Benefits?
* Wylie Burke and Nancy Press
* Commentary on the Outcomes Phase of the Translational Cycle
* Sara Goering, Suzanne Holland, and Kelly A. Edwards
* 11. Bringing the "Best Science" to Bear on Youth Suicide: Why
Community Perspectives Matter
* Rosalina James and Helene Starks
* 12. Conclusion
* Kelly A. Edwards, Sara Goering, Suzanne Holland and Maureen Kelley